Since 1992, the Brugada syndrome has been increasingly recognized worldwide, although its incidence and distribution remain unclear. In Asia, several cases have been reported in Japan, Thailand, Singapore, and Vietnam. However, little information is available from the Chinese population. Since June 1997, we have identified 10 patients with the diagnosis of the Brugada syndrome from six hospitals in Taiwan. All patients were male with the mean age of 46 ± 7 years (range 36–61). They all had a normal chemistry profile, coronary angiography and echocardiography. Clinical presentations varied from seizure and syncope to sudden cardiac death. MRI and ultrafast CT of the heart did not show any abnormalities. Sustained ventricular tachycardia/ventricular fibrillation (VF) was induced in 7 of 8 patients who underwent an electrophysiologic study. The pharmacological provocation test was positive in 4 of 5 patients. One of the 4 patients who had a genetic study showed SCN5A gene mutation. An implantable cardioverter defibrillator (ICD) was implanted in 8 patients. During a mean follow-up of 29 ± 17 months (range 2–54), 3 of 8 patients who had an ICD received appropriate ICD discharges after implantation. These 3 patients who were subsequently treated with antiarrhythmic agents have had no further recurrent ICD discharges. Two patients who refused ICD implantation are alive and well without taking antiarrhythmic agents. Our study showed that the clinical characteristics of our patients are similar to those described in the literature and that ICD is an effective treatment modality for patients with recurrent VF. However, antiarrhythmic agents may be beneficial for suppressing arrhythmia recurrences in selected patients.

1.
Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992;20:1391–1396.
2.
Bjerregaard P, Gussak I, Kotar SL, Gessler JE, Janosik D: Recurrent syncope in a patient with prominent J-wave. Am Heart J 1994;127:1426–1430.
3.
Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S: Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061–1070.
4.
Antzelevitch C, Brugada P, Brugada J, Brugada R, Nademanee K, Towbin J: Clinical Approaches to Tachyarrhythmias, vol 10: The Brugada Syndrome. Mount Kisco, Futura Publishing, 1999.
5.
Wang Q, Li Z, Shen J, Keating MT: Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996;34:9–16.
6.
Nademanee KK, Veerakul G, Nimmannit S, Chaowakul V, Bhurpanyo K, Likittanasombat K, Tunsanga K, Kuasirikul S, Malasit P, Tansupasawadikul S, Tatsanavivat P: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595–2600.
7.
Teo WS, Kam R, Tan RS, Maglana M, Lim YL: The Brugada syndrome in a Chinese population. Int J Cardiol 1998;65:281–286.
8.
Kalla H, Yan G-X, Marinchak R: Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: A Brugada syndrome variant? J Cardiovasc Electrophysiol 2000;11:95–98.
9.
Dock W: Transitory ventricular fibrillation as a case of syncope and its prevention by quinidine sulfate. Am Heart J 1929;4:709–714.
10.
Dubner SJ, Gimeno GM, Elencwajg B, Leguizamon J, Tronge JE, Quinteiro R: Ventricular fibrillation with spontaneous reversion on ambulatory ECG in the absence of heart disease. Am Heart J 1983;105:691–693.
11.
Patt MV, Podrid PJ, Friedman PL, Lown B: Spontaneous reversion of ventricular fibrillation. Am Heart J 1988;115:919–923.
12.
Kontny F, Dale J: Self-terminating idiopathic ventricular fibrillation presenting as syncope: A 40-year follow-up report. J Intern Med 1990;227:211–213.
13.
Alings M, Wilde A: ‘Brugada’ syndrome: Clinical data and suggested pathophysiological mechanism. Circulation 1999;99:666–673.
14.
Osher HL, Wolff L: Electrocardiographic pattern simulating acute myocardial injury. Am J Med Sci 1953;226:541–545.
15.
Otto CM, Tauxe RV, Cobb LA, Greene HL, Gross BW, Werner JA, Burroughs RW, Samson WE, Weaver WD, Trobaugh GB: Ventricular fibrillation causes sudden death in Southeast Asian immigrants. Ann Intern Med 1984;101:45–47.
16.
Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR: The Brugada syndrome: Clinical, electrophysiological and genetic aspects. J Am Coll Cardiol 1999;33:5–15.
17.
Antzelevitch C: The Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:513–516.
18.
Veldkamp MW, Viswanathan PC, Bezzina C, Baartscheer A, Wilde AAM, Balser JR: Two distinct congenital arrythmias evoked by a multidysfunctional Na(+) channel. Circ Res 2000;86:e91–e97.
19.
Matsuo K, Shimizu W, Kurita T, Inagaki M, Aihara N, Kamakura S: Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:508–512.
20.
Brugada R, Brugada J, Antzelevitch C: Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right buddle branch block but structurally normal hearts. Circulation 2000;101:510–515.
21.
Brugada J, Brugada P, Brugada R: Ajamaline unmasks right bundle branch block-like and ST segment elevation in V1–V3 in patients with idiopathic ventricular fibrillation (abstract). PACE 1996;19:599.
22.
Brugada P, Geelen P, Brugada R, Mont L, Brugada J: Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:1004–1007.
23.
Brugada J, Brugada P: Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol 1997;8:325–331.
24.
Ikeda T, Sakurada H, Sakabe K, Sakata T, Takami M, Tezuka N, Nakae T, Noro M, Enjoji Y, Tejima T, Sugi K, Yamaguchi T: Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: Insight into risk stratification. J Am Coll Cardiol 2001;37:1628–1634.
25.
Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O’Brien RE, Schuze-Bahr E, Keating MT, Towbin JA, Wang Q: Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998;392:293–296.
26.
Priori SG, Napolitano C, Gasparini M, Pappone C, Bella PD, Brignole M, Giordano U, Giovannini T, Menozzi C, Bloise R, Crotti L, Terreni L, Schwartz PJ: Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000;102:2509–2515.
27.
Kakishita M, Kurita T, Matsuo K, Taguchi A, Suyama K, Shimizu W, Aihara N, Kamakura S, Yamamoto F, Kobayashi J, Kosakai Y, Ohe T: Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:1646–1653.
28.
Chen SM, Kuo CT, Lin KH, Chiang FT: Brugada syndrome with mutation of the cardiac sodium channel gene in a Taiwanese patient. J Formos Med Assoc 2000;99:860–862.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.